Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
  • Peer groups
    • HR Peer Group
    • Recruitment Peer Group
    • Marketing Peer Group
    • PA Peer Group
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job
    • Peer groups
      • HR Peer Group
      • Recruitment Peer Group
      • Marketing Peer Group
      • PA Peer Group

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    OutSee’s leadership team – James Peach (Left), COO, Dr Julian Gough (Centre), CEO and Founder, and Dr Chang Lu (Right), CSO
    12 January 2026

    OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate

    Oversubscribed £2.5M seed round led by Ahren Innovation CapitalStrategic collaboration with o2h to progress drug discovery programmeCambridge, UK, 12 January 2026: OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery...

    Steve Smith, CEO, iXCells Biotechnologies
    12 January 2026

    iXCells Biotechnologies appoints Steve Smith as CEO

    Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services ...

    Team consulting partner with London Institute for Healthcare Engineering
    9 January 2026

    Advancing UK MedTech innovation with collaboration - London Institute for Healthcare Engineering partnership with Team Consulting

    Team Consulting is delighted to announce a new collaboration with the London Institute for Healthcare Engineering (LIHE), part of King’s College London. Drawing on our 40-year track record in healthcare innovation, this partnership marks an acceleration in the journey from breakthrough ...

    FairJourney Bio
    12 January 2026

    FairJourney Bio launches cryo-EM services with advanced laboratories in San Diego, USA

    Expanded offering provides high-resolution structural insights to support antibody discovery and biologic designPORTO, Portugal, and SAN DIEGO, USA, 12 January 2026 – FairJourney Bio (FJBio), a leading global provider of antibody discovery and development services, today announced ...

    Rebecca Simmons, PhD, COO, Qureight
    12 January 2026

    Qureight appoints Rebecca Simmons as Chief Operating Officer

    Experienced operational leader across medical research and deep tech appointed to support sustainable growth as part of Qureight’s strategy to scale company operationsCambridge, UK, 12 January 2026 – Qureight, a techbio company advancing the understanding of lung and heart disease throu...

    www.enhancedgenomics.com
    9 January 2026

    Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors

    Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases ...

    Why 454 Million People Are Waiting for a Device Already in Their Pocket
    9 January 2026

    Why 454 million people are waiting for a device already in their pocket

    The Smartphone Revolution in Respiratory Care Has Arrived, And It Changes EverythingHere's an uncomfortable truth: we've had the technology to transform respiratory diagnostics for years. It's sitting in your pocket right now. ...

    FairJourney Bio
    8 January 2026

    FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference

    PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 – 15, 2026...

    graphic
    7 January 2026

    From speed to proof: what happens when innovation meets system maturity

    For many founders, the early phase of innovation is familiar territory. A strong idea gains traction, early pilots show promise, and momentum builds around speed — speed to prototype, speed to market, speed to scale. ...

    eProtein Discovery at National Taiwan University
    7 January 2026

    Nuclera eProtein Discovery System installed at leading Universities in Taiwan

    Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in AsiaSystem strengthens Taiwan’s capabilities in protein drug discovery researchCambridge, UK, and Boston MA, USA, 07 January 2026: Nuclera, the...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 49
    • Page 50
    • Current page 51
    • Page 52
    • Page 53
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS